FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance-Reference-Cited by-同舟云学术

FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance

Published:2015-07-08 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Bernardo Barbara,Lu Min,Bandyopadhyay Gautam,Li Pingping,Zhou Yingjiang,Huang Jie,Levin Nancy,Tomas Eva M.,Calle Roberto A.,Erion Derek M.,Rolph Timothy P.,Brenner Martin,Talukdar Saswata

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep11382.pdf

Reference40 articles.

1. Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. The Journal of clinical investigation 115, 1627–1635, 10.1172/JCI23606 (2005).

2. Inagaki, T. et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell metabolism 5, 415–425, 10.1016/j.cmet.2007.05.003 (2007).

3. Lee, D. V. et al. Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes. PloS one 9, e111767, 10.1371/journal.pone.0111767 (2014).

4. Xu, J. et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure and improves insulin sensitivity in diet-induced obese mice. Diabetes 58, 250–259, 10.2337/db08-0392 (2009).

5. Kharitonenkov, A. et al. Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319. PloS one 8, e58575, 10.1371/journal.pone.0058575 (2013).

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of novel adipokines and adipose-derived extracellular vesicles (ADEVs): Connections and interactions in liver diseases;Biochemical Pharmacology;2024-04

2. Brown adipocyte and browning thermogenesis: metabolic crosstalk beyond mitochondrial limits and physiological impacts;Adipocyte;2023-07-24

3. Fibroblast growth factor 21 as a potential master regulator in metabolic disorders;American Journal of Physiology-Endocrinology and Metabolism;2023-05-01

4. A Multiomics Atlas of Brown Adipose Tissue Development Over Time;Endocrinology;2023-04-17

5. Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease;Journal of Controlled Release;2023-03